India Investing

ULIPs and Endowment Plans: The Most Expensive Investment Mistake in India

ULIPs and endowment plans have been India's financial distributors' most profitable products — and their customers' most costly investment decisions. Here is why the math never works in the investor's favour.

2 July 202610 min read
Listen to this article

Millions of Indian households hold ULIPs and endowment plans, often purchased because a trusted family friend, bank manager, or insurance agent recommended them. The products are presented as providing "both insurance and investment." Combining insurance and investment in one product reliably delivers poor versions of both.

How ULIPs Actually Work

A ULIP takes your premium and deducts: policy administration charges, premium allocation charges (typically 2–5% of each premium), fund management charges (1–1.5% per year), and mortality charges (cost of the insurance cover). What remains is invested in market-linked funds. The sum assured (death benefit) is typically modest — often 10 times the annual premium.

In the first 3–5 years, a significant fraction of your premium goes to charges rather than investment. If you surrender within 3 years, you receive the surrender value, often dramatically below what you paid in. IRDA regulations have reduced ULIP charges significantly since 2010, and modern ULIPs are better than earlier versions — but the fundamental problem of mixing insurance and investment persists.

ProductCost StructureInvestment ReturnInsurance Adequacy
ULIP (typical)2–4% annual chargesMarket return minus chargesLow (10× premium cover)
Endowment plan20–30% commission on early premiums4–5% guaranteed returnVery low
Term + MF combinationTerm: ₹8,000–15,000/yr for ₹1 crore; MF: 0.1–1% TERMarket return minus 0.1–1%Adequate (₹1 crore cover)

The Endowment Plan Problem

Endowment plans offer a guaranteed maturity benefit after 15–20 years. The implied annual return from major Indian insurers is typically 4–5% — below fixed deposit returns. Meanwhile, they tie up premium payments for 15–20 years with significant exit penalties. The insurance component is minimal — sum assureds of 10–20× annual premium are grossly inadequate for a primary income earner with dependents.

The term insurance + mutual fund alternative

For a 35-year-old: • Pure term insurance: ₹1 crore cover for 25 years costs approximately ₹12,000–15,000/year • Monthly SIP: whatever remains from the ULIP premium budget This delivers: far superior insurance coverage, significantly better investment returns, complete flexibility and liquidity, and no surrender penalties. The only thing missing is the "comfort" of a single product — which is not a financial benefit.

What to Do If You Already Have a ULIP or Endowment Plan

If a ULIP is less than 3 years old: the decision is complex because surrender charges are highest in early years. Calculate the break-even point: how many years until the investment component, compounding at realistic fund returns minus charges, matches what you would earn from an alternative investment started today. Often the answer is 5–7 years, making continuation questionable.

If a ULIP is past year 5 and charges have moderated: compare fund options available within the ULIP versus best available mutual funds, adjusted for remaining charges. Some ULIPs after year 5 are reasonable — an independent advisor can model the specific numbers.

Endowment plans with premiums complete: let them mature. Still paying premiums: consider making the plan "paid-up" (stopping premiums while keeping the policy active at a reduced benefit) and redirecting those premiums to term insurance + mutual fund. Surrendering mid-way typically produces terrible returns.

This article is for educational purposes only. It does not constitute investment advice. Mutual fund investments are subject to market risks — please read all scheme-related documents carefully before investing.

Want to apply this to your portfolio?

General knowledge is the starting point. A plan built around your specific goals is what actually moves the needle.